Some sociodemographic features and factors associated with treatment in patients with schizoprenia;Şizofreni hastalarinda bazi sosyodemografik özellikler ve tedavi ile ilişkili etkenler

Anadolu Psikiyatri Dergisi

Volumn 8, Issue 2, 2007, Pages 102-112

  Belli, Hasan ^a   Özçetin, Adnan ^b   Ertem, Ümit ^a   Alpay, Emrehan ^c   Bahçebaşi, Talat ^b   Kiran, Ü Kemal ^a   Baykiz, A Fuat ^d   Bayik, Yilmaz ^a  

^a Hastaliklari Hastanesi ^*  (Turkey)

^b Yogun Bak m Section   (Turkey)

^c Elazi Devlet Hastanesi   (Turkey)

^d Asker Hastanesi   (Turkey)

Author keywords

Schizophrenia; Sociodemographic features; Substance; Treatment

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANNABIS SMOKING; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; CULTURAL FACTOR; DEMOGRAPHY; DISEASE CLASSIFICATION; DOCTOR PATIENT RELATION; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; EMPLOYMENT; FAMILY STUDY; FEMALE; HEBEPHRENIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OUTPATIENT CARE; PARANOID SCHIZOPHRENIA; PATIENT COMPLIANCE; PRODUCTIVITY; QUALITY OF LIFE; READING; RESIDUAL SCHIZOPHRENIA; SCHIZOPHRENIA; SOCIAL INTERACTION; SOCIAL SUPPORT; SOCIOECONOMICS; SUBSTANCE ABUSE; TREATMENT PLANNING; TURKEY (REPUBLIC); UNSPECIFIED SIDE EFFECT; WRITING;

EID: 34547546981     PISSN: 13026631     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Riecher-Rössler A, Hafner H. Gender aspects in schizophrenia: bridging the border between social and biological psychiatry. Acta psychiatr Scand 2000; 102(Suppl. 407):58-62.
2. Takahashi S, Matsuura M, Tanabe E, Yara K, Nonaka K, Fukura Y et al. Age at onset of schizophrenia: gender differences and influences of temporal socio-economic change. Psychiatry Clin Neurosci 2000; 54:153-156.
3. Gangadhar BN, Panner SC, Subbakrishna DK, Janakiramaiah N. Age at onset and schizophrenia: reversed gender effect. Acta psychiatr Scand 2002; 105:317-319.
4. Karşidaǧ C, Alpay N, Kocabiyik A. Şizofreni ve sigara baǧimliliǧi. Düşünen Adam 2005; 18:13-20.
5. Gureje O. Gender and schizophrenia: age at onset and sociodemographic attributes. Acta Psychiatr Scand 1991; 83:402-405.
6. Usall J, Araya S, Ochoa S, Busquets E, Gost A, Marquez M. Gender differences in a sample of shizophrenic outpatients. Compr Psychiatry 2001; 42:301-305.
7. Angermeyer MC, Goldstein JM. Gender differences in schizophrenia rehospitalization and community survival. Psychol Med 1989; 19:365-382.
8. Angermeyer Me, Kühn L, Goldstein JM. Gender and course of schizophrenia: differences in treated outcomes. Schizophr Bull 1990; 16:293-307.
9. Bhugra D, Hilwing M, Mallet R, Corridan B, Leff J, Neehall J et al. Factors in the onset of schizophrenia: a comparison between London and Trinidad samples. Acta Psyciatr Scand 2000; 101:135-141.
10. Şaylan M, Alptekin K, Akdemir A, Tetik E, Korb FA. The intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study: baseline clinical and functional characeristics and antipsychotic use patterns in Turkey. Bull Clin Psychopharmacol 2004; 14:132-142.
11. Simon AE, Peter M, Hess L, Valterio C. Antipsychotic use in patients with schizophrenia treated in private psychiatry. Swiss Med Weekly 2005; 135:109-105.
12. Mueser KT, Bellack AS, Blanchard JJ. Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychol 1992; 60:845-856.
13. Batel P. Addiction and shizophrenia. Eur Psychiatry 2000; 15:115-122.
14. Kelly C, McCreadie RG. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry 1999; 156:1751-1757.
15. Ripoll N, Bronnec M, Bourin M. Nicotinic recaptors and schizophrenia. Curr Med Res Opin 2004; 20:1057-1074.
16. Amerikan Psikiyatri Birliǧi. Mental Bozukluklarin Tanisal ve Sayimsal El Kitabi. Dördüncü baski (DSM-IV) E Köroǧlu (çev. ed.), Ankara, Hekimler Yayin Birliǧi, 1996.
17. Sharma VK, Srinivasa MR, Kishore Kumar KV, Agarwal MR, Wilkinson G. Comparison of patients with schizophrenia from Liverpool, England and Sakalwara-Bangalore, India. Int J Soc Psychiatry 1998; 14:225-230.
18. Kaplan HI, Sadock BJ. Schizophrenia. Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry, eight ed., chap. 13, Giza, Mass Publishing, 1998, s.456-491.
19. Evren B, Evren C, Karamustafalioǧlu N, Tomruk N, Alpay N. Şizofrenili hastalarda cinsiyet fakliliǧi: sosyodemografik ve klinik açidan karşilaştirma. Türkiye'de Psikiyatri 2002; 2:114-124.
20. Brambilla P, Barale F, Caverzas E, Tognoni G, Barbui C. Clozapine-treated subjects with treatment-resistant schizophrenia: a systematic review of experimental and observational studies. Int Clin Psychopharmacol 2002; 17:189-195.
21. Misdrahi D, Llorca PM, Lancon C, Bayle FC. Compliance in schizophrenia: predictive factors, therapeutical Considerations and research implications. Encephale 2002; 28:266-72.
22. Munk-Jorgensen P. Schizophrenia in Denmark. Incidence and utilization of psychiatric institutions. Acta Psychiatr Scand 1986; 73:172-180.
23. Bozkurt AI, Sahinoz S, Ozcirpici B, Ozgur S, Sahinoz T, Acemoglu H et al. Patterns of active and passive smoking, and associated factors, in the South-east Anatolian Project (SEAP) region in Turkey. BMC Public Health 2006; 25:6-15.
24. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area Study. JAMA 1990; 264:2511-2518.